OpGen, Inc. Profile Avatar - Palmy Investing

OpGen, Inc.

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for t…

Medical - Diagnostics & Research
US, Rockville [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

OpGen, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of OPGN's Analysis
CIK: 1293818 CUSIP: 68373L307 ISIN: US68373L4068 LEI: - UEI: -
Secondary Listings
OPGN has no secondary listings inside our databases.